Aegis Financial Corp Takes Position in Acacia Research Corporation $ACTG

Aegis Financial Corp bought a new stake in shares of Acacia Research Corporation (NASDAQ:ACTG) during the 1st quarter, HoldingsChannel.com reports. The fund bought 491,086 shares of the business services provider’s stock, valued at approximately $2,362,000. Acacia Research makes up about 0.4% of Aegis Financial Corp’s holdings, making the stock its 25th largest position.

Several other institutional investors have also bought and sold shares of the stock. State Street Corp grew its stake in shares of Acacia Research by 12.8% in the 4th quarter. State Street Corp now owns 3,145,981 shares of the business services provider’s stock worth $11,766,000 after acquiring an additional 355,916 shares in the last quarter. Bridgeway Capital Management LLC lifted its position in shares of Acacia Research by 65.4% during the fourth quarter. Bridgeway Capital Management LLC now owns 441,886 shares of the business services provider’s stock valued at $1,653,000 after purchasing an additional 174,752 shares in the last quarter. Marshall Wace LLP bought a new position in shares of Acacia Research during the second quarter valued at about $614,000. Peapod Lane Capital LLC boosted its holdings in Acacia Research by 16.5% during the fourth quarter. Peapod Lane Capital LLC now owns 845,954 shares of the business services provider’s stock worth $3,216,000 after purchasing an additional 119,783 shares during the last quarter. Finally, Dimensional Fund Advisors LP boosted its holdings in Acacia Research by 3.4% during the first quarter. Dimensional Fund Advisors LP now owns 2,853,889 shares of the business services provider’s stock worth $13,728,000 after purchasing an additional 95,089 shares during the last quarter. Institutional investors own 86.69% of the company’s stock.

Acacia Research Stock Down 0.7%

ACTG stock opened at $4.57 on Thursday. Acacia Research Corporation has a 1-year low of $3.12 and a 1-year high of $5.27. The stock has a market cap of $441.42 million, a P/E ratio of -25.39 and a beta of 0.43. The stock’s fifty day simple moving average is $4.62 and its two-hundred day simple moving average is $4.50. The company has a current ratio of 8.56, a quick ratio of 8.09 and a debt-to-equity ratio of 0.10.

Acacia Research (NASDAQ:ACTG) last released its earnings results on Thursday, May 7th. The business services provider reported ($0.07) EPS for the quarter, topping analysts’ consensus estimates of ($0.09) by $0.02. Acacia Research had a negative return on equity of 2.81% and a negative net margin of 8.53%.The company had revenue of $54.24 million for the quarter, compared to analysts’ expectations of $50.00 million. During the same period in the previous year, the business posted $0.25 EPS.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings lowered shares of Acacia Research from a “hold (c-)” rating to a “sell (d-)” rating in a research note on Monday, May 11th. One research analyst has rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, Acacia Research presently has a consensus rating of “Hold” and an average price target of $6.00.

About Acacia Research

Acacia Research Corporation is a publicly traded patent licensing company based in New York City. The firm specializes in acquiring patented technologies through a network of wholly owned subsidiaries and seeking licensing agreements or settlements with companies that utilize those technologies. Since its founding in 1993, Acacia has built a business model centered on identifying innovative inventions and monetizing them through patent enforcement and strategic partnerships.

The company’s activities span a broad range of technology sectors, including life sciences, medical devices, software, telecommunications and consumer electronics.